MiNK Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.75
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.24
|
0.00
|
0.24
|
100.00%
|
|
2022-12-31
|
-0.19
|
0.00
|
0.19
|
100.00%
|
|
2022-09-30
|
-0.23
|
-0.19
|
0.04
|
17.39%
|
|
2022-06-30
|
-0.24
|
-0.18
|
0.06
|
25.00%
|
|
2022-03-31
|
-0.21
|
-0.23
|
-0.02
|
-9.52%
|
|
2021-12-31
|
-0.41
|
-0.18
|
0.23
|
56.10%
|
|
2021-09-30
|
-0.20
|
-0.59
|
-0.39
|
-195.00%
|
|
2021-06-30
|
0.00
|
-0.21
|
-0.21
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.60
|
|
2021-12-31
|
-1.19
|
|
2020-12-31
|
-0.70
|
|
2019-12-31
|
-0.18
|